Nivolumab vs Spironolactone
Nivolumab vs Spironolactone: Overview
This comparison examines the pharmacological differences between Nivolumab and Spironolactone.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Spironolactone: Mineralocorticoid receptor antagonist.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Spironolactone β 1.4 hours.
Chemical Properties
Molecular Formula: Spironolactone β C24H32O4S.
Molecular Weight: Spironolactone β 416.5740 g/mol.
Type: Nivolumab β Antibody; Spironolactone β Small molecule.